1 week ago 8

News24 | Sunfoil owner reaches R101m competition settlement amid price-fixing, market division claims

Share this via

SA's top competition watchdog has reached a R101 million settlement with Sunfoil cooking oil owner Willowton Group after an eight-year legal battle over price fixing and market division allegations.
Read Entire Article
  1. Homepage
  2. Headlines
  3. News24 | Sunfoil owner reaches R101m competition settlement amid price-fixing, market division claims

From Twitter

Related

Government worker says she was 'absolutely infuriated' by DOGE email asking her to say what she did last week

Government worker says she was 'absolutely infuriated' by DO...

59 minutes ago 0
Secretive US Space Force plane shares rare photo of Earth from orbit

Secretive US Space Force plane shares rare photo of Earth fr...

1 hour ago 0
Boston councilwoman backs off after ridiculing Tom Homan's employment history in fiery post: 'I understand'

Boston councilwoman backs off after ridiculing Tom Homan's e...

1 hour ago 0
Why NHL Commissioner Gary Bettman isn’t sure 4 Nations Face-Off will happen next season

Why NHL Commissioner Gary Bettman isn’t sure 4 Nations Face-...

1 hour ago 0

Comments

Trending

1. Macron
2. Hims stock
3. Apple 500 billion investment
4. Joel Embiid
5. Apple Stock
6. Harrison Ford
7. Al Trautwig
8. PBS KIDS
9. Nvidia stock
10. Oscars

Popular News

Trump administration fires more than a dozen immigration jud...
1 week ago
Trump administration fires more than a dozen immigration judges

Hamas hands over three Israeli captives in sixth phase of pr...
1 week ago
Hamas hands over three Israeli captives in sixth phase of prisoner exchange

Why has a former Tory MP decide to serve in Ukraine’s milita...
1 week ago
Why has a former Tory MP decide to serve in Ukraine’s military? | BBC News

'Cobra Kai' is a rare show that kids and adults both enjoy: ...
1 week ago
'Cobra Kai' is a rare show that kids and adults both enjoy: 'That's the really cool thing about' the series, its co-creator says

ASCO GU｜RemeGen Announced Highly Encouraging Data from the P...
1 week ago
ASCO GU｜RemeGen Announced Highly Encouraging Data from the Phase II Clinical Trial Evaluating Disitamab Vedotin plus Immunotherapy as Perioperative Regimen for Bladder Cancer
About Us · Contact Us · Terms & Conditions · Help · Privacy ·

© Latest News Search Engine - Global and Local Breaking News 2025. All rights are reserved